HBM Healthcare Investments AG Stock

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange 11:30:02 2024-05-17 am EDT 5-day change 1st Jan Change
199.8 CHF +0.91% Intraday chart for HBM Healthcare Investments AG +0.91% +9.42%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2025 * 46.1M 50.69M Sales 2026 * 131M 144M Capitalization 1.38B 1.52B
Net income 2025 * 18M 19.79M Net income 2026 * 103M 113M EV / Sales 2025 * 28.8 x
Net cash position 2025 * 53M 58.28M Net cash position 2026 * 75M 82.47M EV / Sales 2026 * 9.97 x
P/E ratio 2025 *
82.6 x
P/E ratio 2026 *
13.6 x
Employees 700
Yield 2025 *
2.81%
Yield 2026 *
2.81%
Free-Float 82.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.91%
1 week+0.91%
Current month+7.19%
1 month+8.23%
3 months+23.18%
6 months+19.78%
Current year+9.42%
More quotes
1 week
195.40
Extreme 195.4
202.00
1 month
180.60
Extreme 180.6
202.00
Current year
155.00
Extreme 155
202.00
1 year
135.20
Extreme 135.2
210.00
3 years
135.20
Extreme 135.2
367.00
5 years
135.20
Extreme 135.2
367.00
10 years
77.65
Extreme 77.65
367.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 01-06-30
Director of Finance/CFO 54 11-10-31
Corporate Secretary 60 -
Members of the board TitleAgeSince
Chairman 68 09-05-31
Director/Board Member 69 21-06-17
Director/Board Member 52 11-12-31
More insiders
Date Price Change Volume
24-05-17 199.8 +0.91% 2,973
24-05-16 198 +0.41% 6,234
24-05-15 197.2 -0.40% 2,932
24-05-14 198 -0.80% 2,767
24-05-13 199.6 +0.81% 4,347

Delayed Quote Swiss Exchange, May 17, 2024 at 11:30 am EDT

More quotes
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
199.8 CHF
Average target price
236 CHF
Spread / Average Target
+18.12%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW